Adrienne Einhorn
Internal Medicine · Carmel, INNPI 1548463987
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 253 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,105 and has fallen 98.5% since, to $16 in 2024.
Across 253 payments — averaging $12.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$479
- AstraZeneca$439
- Novo Nordisk$333
- GSK$210
- Merck$182
- Amarin Pharma, Inc.$181
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,188100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 56 | $479 |
| AstraZeneca | 30 | $439 |
| Novo Nordisk | 36 | $333 |
| GSK | 16 | $210 |
| Merck | 16 | $182 |
| Amarin Pharma, Inc. | 10 | $181 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $174 |
| Sanofi-aventis U.S. LLC | 11 | $156 |
| Astellas Pharma US Inc | 7 | $127 |
| Eisai Inc. | 8 | $122 |
| AbbVie(2 entities) | 6 | $109 |
| Pfizer | 7 | $102 |
| Kowa Pharmaceuticals America, Inc. | 6 | $72 |
| Novartis | 4 | $58 |
| Tactile Systems Technology Inc | 4 | $56 |
| Arbor Pharmaceuticals, Inc. | 1 | $53 |
| Romark Laboratories, LC | 2 | $46 |
| Johnson & Johnson | 3 | $46 |
| Amgen | 2 | $34 |
| Sanofi Pasteur Inc. | 2 | $27 |
| Boehringer Ingelheim | 2 | $25 |
| Shire North American Group Inc | 1 | $22 |
| Nalpropion Pharmaceuticals LLC | 1 | $20 |
| Abbott | 1 | $19 |
| Mylan Specialty L.p. | 1 | $19 |
| Ironshore Pharmaceuticals Inc. | 1 | $15 |
| Sanofi | 1 | $13 |
| Adlon Therapeutics L.p. | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
| Vertiflex, Inc. | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $11 |
How this compares
$3,188 in reported general payments places this provider in the 85th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tramadol Hcl | 16 | $481 |
| Levothyroxine Sodium | 33 | $315 |
| Rosuvastatin Calcium | 32 | $306 |
| Atorvastatin Calcium | 16 | $206 |
| Lisinopril | 11 | $62 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Carmel
- Brian UlmerCarmel$29K
- Abhinav SinghGreenwood$733K
- Girish KunapareddyTerre Haute$329K
- Raj VuppalanchiIndianapolis$279K
- Joseph Arulandula Porte$251K
- Napoleon MamintaIndianapolis$116K
- Jennifer PaisleyLawrenceburg$112K
- Allon FriedmanIndianapolis$111K
- John AyresIndianapolis$107K
- Emily FrankLebanon$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.